Cytomegalovirus clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for

  • CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

    open to eligible people ages 18 years and up

    This is a phase 2, prospective cohort clinical trial evaluating the utilization of CMV T Cell Immunity Panel (CMV-TCIP) assay to guide the duration of primary CMV prophylaxis in CMV-seropositive recipients of allogeneic stem cell transplant or recipients receiving a stem cell graft from a CMV serology positive donor.

    Orange, California

Our lead scientists for Cytomegalovirus research studies include .

Last updated: